Back
NovaBay Pharmaceuticals Vs. Pro-Dex Industry Stock Comparison
Sell
50
NBY
NovaBay Pharmaceuticals
Last Price:
$0.62
Seasonality Move:
15.02%
Buy
64
PDEX
Pro-Dex
Last Price:
$49.45
Seasonality Move:
10.27%
Sell
50
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.64. The Score for NBY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.64The current trend is relatively stagnant and NBY is experiencing slight buying pressure.
PDEX Stock Price Chart
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 57.72 | Buy |
Chaikin Money Flow: | 6818 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.53 - 0.61) | Buy |
Bollinger Bands (100): | (0.52 - 0.7) | Buy |
PDEX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.21 | Buy |
Relative Strength Index (14 RSI): | 52.15 | Buy |
Chaikin Money Flow: | -24917 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.35 - 52.25) | Buy |
Bollinger Bands (100): | (24.83 - 47.33) | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.62 | Buy |
20-day SMA: | 0.57 | Buy |
50-day SMA: | 0.63 | Buy |
200-day SMA: | 1.65 | Sell |
8-day EMA: | 0.62 | Buy |
20-day EMA: | 0.6 | Buy |
50-day EMA: | 0.63 | Buy |
200-day EMA: | 4.27 | Sell |
PDEX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.35 | Buy |
20-day SMA: | 48.65 | Buy |
50-day SMA: | 46.23 | Buy |
200-day SMA: | 27.44 | Buy |
8-day EMA: | 50.04 | Sell |
20-day EMA: | 48.94 | Buy |
50-day EMA: | 45.04 | Buy |
200-day EMA: | 31.49 | Buy |
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.44 per share, and an increase next year of $0.44 per share.
Pro-Dex Earnings Growth & PDEX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.50 per share, and an increase next year of $0.06 per share.
NovaBay Pharmaceuticals Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pro-Dex Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |